FDA Corrects Withdrawal of Approval for 30 Abbreviated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has corrected a notice regarding the withdrawal of approval for 30 abbreviated new drug applications (ANDAs), which was initially announced on March 29, 2024, and was set to be withdrawn as of April 29, 2024. The FDA has reinstated the approvals for six of the ANDAs after receiving a request from Target Health LLC.